medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2020, Number 1

<< Back Next >>

Rev Latin Infect Pediatr 2020; 33 (1)

Influenza: interesting data

Gutiérrez E, Gutiérrez IF, Mojica JA, Mariño C, López P

Language: Spanish
References: 12
Page: 19-27
PDF size: 261.89 Kb.


ABSTRACT

Influenza is a disease of viral etiology that mainly manifests itself with a symptomatology involving the respiratory tract and can vary from mild to moderate to severe and become a major cause of morbidity and mortality depending on the age groups affected,(It is more severe in the extremes of life, under 5 years and over 60) and in those with previous comorbidities (diabetes, obesity, chronic respiratory or cardiovascular diseases and others). In 2009, the A(H1N1) strain reached pandemic proportions with mortality between 100,000 and 400,000 subjects. The first pandemic of the 21st century. This virus, designated today as A(H1N1) pdm09, gradually became a seasonal virus as of 2010, and as such continues to circulate endemically to date in Latin American countries. Surveillance of influenza virus circulation is essential, both globally and at the country level. Worldwide, more than 120 countries have a National Influenza Centre responsible for surveillance of virus circulation. Global and regional epidemiology from North, Central and South America in selected countries is reviewed and treatment options and available vaccines are reviewed. Also, the recommendations of the World Health Organization (WHO). Country policies are reviewed with respect to their statistics, vaccination policies, and financial resources.


REFERENCES

  1. Center for Diseases Control and Prevention (CDC) [Internet]. 2018 [actualizado 10 julio 2019; citado 28 enero de 2020]. Disponible en: https://www.cdc.gov/flu/index.htm

  2. Reproduced and adapted with permission of Dr Masato Tashiro, Director, Center for Influenza Virus Research, National Institute of Infectious Diseases [internet] 2009 (NIID) Japan. [citado 28 de enero de 2020] Disponible en: https://www.niid.go.jp/niid/en/flu-e.html

  3. Weekly /Influenza Report EW 3/Regional Update: Influenza & Others Respiratory Viruses. PAHO/OPS influenza regional update [internet] 28 de enero de 2020 [citado el 03 de febrero 2020] Disponible en: https://www.paho.org/hq/index.php?option=com_docman&view=download&category_slug=see-influenza-reports-by-year-4302&alias=51471-regional-update-influenza-epidemiological-week-3-january-28-2020&Itemid=270&lang=en

  4. Influenza Global Update 358 Based on data up to December 22, 2019. [Internet] [actualizado 06 de enero de 2020; citado 28 de enero 2020]. Disponible en: https://www.who.int/influenza/surveillance_monitoring/updates/2020_01_06_surveillance_update_358.pdf?ua=1

  5. World Health Association. Influenza [Internet] [actualizado 6 de noviembre 2018; citado 28 de enero 2020]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)

  6. WHO/IVB Database, Map production Immunization Vaccines and Biologicals (IVB), World Health Organization. [Internet] Department of Immunization, Vaccine and Biologicals (Geneva 27, Switzerland); 2017 [actualizado 13 de junio 2017; citado 28 de enero 2020]. Disponible en: https://extranet.who.int/ivb_docs/reports/catalogue

  7. Committee on Infectious Diseases. Recommendations for Prevention and Control of Influenza in Children, 2017-2018. Pediatrics [Internet]. 2017 [citado 28 de enero 2020]; 140 (4): 10-18. Disponible en: https://pediatrics.aappublications.org/content/pediatrics/140/4/e20172550.full.pdf

  8. Flumaraton [Internet]. Londres: Editado por el redactor del personal de PBR; 2019 [actualizado 5 de noviembre 2019; citado 28 de enero 2020]. Disponible en: https://www.flumaraton.com/post/la-fda-aprueba-nueva-formula-de-fluzone-de-sanofi-en-personas-mayores.

  9. Center for Diseases Control and Prevention (CDC) [Internet]. 2020 [actualizado 17 enero 2020; citado 02 febrero de 2020]. Disponible en: https://espanol.cdc.gov/enes/flu/season/faq-flu-season-2019 / 2020.htm#anchor_1568639330820

  10. Grohskopf LA, Alyanak E, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevención y control de la influenza estacional con vacunas: recomendaciones del Comité Asesor sobre Prácticas de Inmunización - Estados Unidos, temporada de influenza 2019-20. MMWR [Internet]. 2019 [citado 02 febrero de 2020]; 68 (3): 1-21. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713402/

  11. Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM. Guías de práctica clínica de la Sociedad de Enfermedades Infecciosas de América: Actualización de 2018 sobre diagnóstico, tratamiento, quimioprofilaxis y manejo de brotes institucionales de la influenza estacional. Clin Infect Dis [Internet]. 2019 [citado 02 febrero de 2020]; 68 (6): 895-902. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769232/

  12. Hayden FG, Sugaya N, Hirotsu N, Lee N, Jong MD, Hurt AC et al. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018; 379: 913-923.




2020     |     www.medigraphic.com